Home > Insider Trading > Filing (0001140361-18-030422)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1301501	Achaogen Inc	AKAO	Pharmaceutical Preparations (2834)	680533693

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1738144	Janet Dorling	C/O Achaogen, Inc. 1 Tower Place #300 South San Francisco CA 94080	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-06-26	1,300	$0.00	24,269	No	4	A	Direct
Common Stock	Disposition	2018-06-26	450	$9.59	23,819	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2018-06-26	6,000	$0.00	6,000	$10.64

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,000		2028-02-08	No	4	A	Direct

Footnotes

On February 8, 2018, the issuer granted the reporting person Restricted Stock Units ("RSUs") and a stock option that each vest upon the achievement of certain milestones. On June 26, 2018, one of the milestones was achieved, resulting in vesting of a portion of the RSUs and shares subject to the option.
Includes (i) 2,208 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2018 and (ii) 18,400 RSUs.
The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of RSUs of the Issuer.
The option is fully vested and exercisable.